Alcoholism: Allostasis and beyond

Alcoholism: Clinical and Experimental Research

Volumn 27, Issue 2, 2003, Pages 232-243

  Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alcoholism; Allostasis; Corticotropin Releasing Factor; Extended Amygdala; Neuropeptide Y

Indexed keywords

4 AMINOBUTYRIC ACID; CORTICOTROPIN RELEASING FACTOR; DOPAMINE; GLUTAMIC ACID; NEUROPEPTIDE Y; NEUROTRANSMITTER; OPIATE PEPTIDE; SEROTONIN;

ABSTINENCE; ADAPTATION; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; AMYGDALOID NUCLEUS; BRAIN; CHRONIC DISEASE; COMPULSION; DISEASE ASSOCIATION; DRINKING BEHAVIOR; HEREDITY; HOMEOSTASIS; JOB PERFORMANCE; NEUROCHEMISTRY; NEUROTRANSMISSION; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RELAPSE; REVIEW; REWARD; SOCIAL ASPECT; SOCIAL STATUS; STRESS; STRIA TERMINALIS; WITHDRAWAL SYNDROME;

ALCOHOLISM; AMYGDALA; ANIMALS; AROUSAL; BRAIN MAPPING; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; ETHANOL; HUMANS; MOTIVATION; NERVE NET; NEUROPEPTIDE Y; PROSENCEPHALON; REWARD; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA; TERMINALIS;

EID: 0037329682     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000057122.36127.C2     Document Type: Review

References (102)

1. Adrian TE, Allen JM, Bloom SR, Ghatei MA, Rossor MN, Roberts GW, Crow TJ, Tatemoto K, Polak JM (1983) Neuropeptide Y distribution in human brain. Nature (Lond.) 306:584-586.
2. Alheid GF, De Olmos JS, Beltramino CA (1995) Amygdala and extended amygdala, in The Rat Nervous System (Paxinos G ed), pp 495-578, Academic Press, San Diego.
3. Allen YS, Roberts GW, Bloom SR, Crow TJ, Polak JM (1984) Neuropeptide Y in the stria terminalis: evidence for an amygdalofugal projection. Brain Res 321:357-362.
4. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Press, Washington, DC.
5. Badia-Elder NE, Stewart RB, Powrozek TA, Roy KF, Murphy JM, Li TK (2001) Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats. Alcohol Clin Exp Res 25:386-390.
6. Bespalov A, Lebedev A, Panchenko G, Zvartau E (1999) Effects of abused drugs on thresholds and breaking points of intracranial self-stimulation in rats. Eur Neuropsychopharmacol 9:377-383.
7. Boismare F, Daoust M, Moore N, Saligaut C, Lhuintre JP, Chretien P, Durlach J (1984) A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmacol Biochem Behav 21:787-789.
8. Chalmers DT, Lovenberg TW, De Souza EB (1995) Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 15:6340-6350.
9. Clark JT, Kalra PS, Crowley WR, Kalra SP (1984) Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-429.
10. Deitrich RA, Dunwiddie TV, Harris RA, Erwin VG (1989) Mechanism of action of ethanol: initial central nervous system actions. Pharmacol Rev 41:489-537.
11. De Witte P, Bada MF (1983) Self-stimulation and alcohol administered orally or intraperitoneally. Exp Neurol 82:675-682.
12. Dong HW, Petrovich GD, Swanson LW (2001) Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev 38:192-246.
13. Ehlers CL, Li TK, Lumeng L, Hwang BH, Somes C, Jimenez P, Mathe AA (1998) Neuropeptide Y levels in ethanol-naive alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. Alcohol Clin Exp Res 22:1778-1782.
14. Epping-Jordan MP, Watkins SS, Koob GF, Markou A (1998) Dramatic decreases in brain reward function during nicotine withdrawal. Nature (Lond.) 393:76-79.
15. Fadda F, Garau B, Marchei F, Colombo G, Gessa GL (1991) MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats. Alcohol Alcohol 26:107-110.
16. Gewiss M, Heidbreder C, Opsomer L, Durbin P, De Witte P (1991) Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol 26:129-137.
17. Gray TS, Magnuson DJ (1992) Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat. Peptides 13:451-460.
18. Gray TS, Piechowski RA, Yracheta JM, Rittenhouse PA, Bethea CL, Van de Kar LD (1993) Ibotenic acid lesions in the bed nucleus of the stria terminalis attenuate conditioned stress-induced increases in prolactin, ACTH and corticosterone. Neuroendocrinology 57:517-524.
19. Heilig M, Murison R (1987) Intracerebroventricular neuropeptide Y suppresses open field and home cage activity in the rat. Regul Pept 19:221-231.
20. Heilig M, Widerlov E (1995) Neurobiology and clinical aspects of neuropeptide Y. Crit Rev Neurobiol 9:115-136.
21. Heilig M, Soderpalm B, Engel JA, Widerlov E (1989) Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl) 98:524-529.
22. Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT (1993) Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8:357-363.
23. Heilig M, Koob GF, Ekman R, Britton, KT (1994) Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 17:80-85.
24. Heimer L, Alheid G (1991) Piecing together the puzzle of basal forebrain anatomy, in The Basal Forebrain: Anatomy to Function, Vol. 295, Experimental Medicine and Biology (Napier TC, Kalivas PW, Hanin I eds), pp 1-42, Plenum Press, New York.
25. Heinrichs SC, Britton KT, Koob GF (1z991) Both conditioned taste preference and aversion induced by corticotropin-releasing factor. Pharmacol Biochem Behav 40:717-721.
26. Heinrichs SC, Menzaghi F, Merlo-Pich E, Hauger RL, Koob GF (1993) Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res 611:18-24.
27. Heyser CJ, Schulteis G, Durbin P, Koob GF (1998) Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18: 125-133.
28. Heyser CJ, Roberts AJ, Schulteis G, Koob GF (1999) Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. Alcohol Clin Exp Res 23:1468-1476.
29. Hodge CW, Samson HH, Lewis RS, Erickson HL (1993) Specific decreases in ethanol- but not water-reinforced responding produced by the 5-HT3 antagonist ICS 205-930. Alcohol 10:191-196.
30. Hoffman PL, Rabe CS, Moses F, Tabakoff B (1989) N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J Neurochem 52:1937-1940.
31. Holter SM, Landgraf R, Zieglgansberger W, Spanagel R (1997) Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res 21:862-868.
32. Hwang BH, Zhang JK, Ehlers CL, Lumeng L, Li TK (1999) Innate differences of neuropeptide Y (NPY) in hypothalamic nuclei and central nucleus of the amygdala between selectively bred rats with high and low alcohol preference. Alcohol Clin Exp Res 23:1023-1030.
33. Hyytia P, Koob GF (1995) GABA-A receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur J Pharmacol 283:151-159.
34. Kask A, Rago L, Harro J (1998) Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats. Regul Pept 75-76:255-262.
35. Khantzian EJ (1985) The self-medication hypothesis of affective disorders: focus on heroin and cocaine dependence. Am J Psychiatry 142:1259-1264.
36. Khantzian EJ (1990) Self-regulation and self-medication factors in alcoholism and the addictions: similarities and differences, in Combined Alcohol and Other Drug Dependence, Vol. 8, Recent Dev Alcohol (Galanter M ed), pp 255-271, Plenum Press, New York.
37. Khantzian EJ (1997) The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 4:231-244.
38. Kohut H (1971) The Analysis of the Self, Vol. 4, The Psychoanalytic Study of the Child. International Universities Press, New York.
39. Koob GF (2002) Allostatic view of motivation: implications for psychopathology, in Motivational Factors in the Etiology of Drug Abuse, Vol. 50, Nebraska Symposium on Motivation (Bevins R, Bardo MT eds), University of Nebraska Press, Lincoln, NE, in press.
40. Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science (Wash. DC) 278:52-58.
41. Koob GF, Heinrichs SC (1999) A role for corticotropin-releasing factor and urocortin in behavioral responses to stressors. Brain Res 848:141-152.
42. Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129.
43. Koob GF, Markou A, Weiss F, Schulteis G (1993) Opponent process and drug dependence: neurobiological mechanisms. Semin Neurosci 5:351-358.
44. Koob GF, Heinrichs SC, Menzaghi F, Pich EM, Britton KT (1994) Corticotropin releasing factor, stress and behavior. Semin Neurosci 6:221-229.
45. Koob GF, Sanna PP, Bloom FE (1998) Neuroscience of addiction. Neuron 21:467-476.
46. Kornetsky C, Bain GT, Unterwald EM, Lewis MJ (1988) Brain stimulation reward: effects of ethanol. Alcohol Clin Exp Res 12:609-616.
47. Kozicz T (2001) Axon terminals containing tyrosine hydroxylase- and dopamine-beta-hydroxylase immunoreactivity form synapses with galanin immunoreactive neurons in the lateral division of the bed nucleus of the stria terminalis in the rat. Brain Res 914:23-33.
48. Le Magnen J, Tran G, Durlach J, Martin C (1987) Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate. Alcohol 4:97-102.
49. Lesur A, Gaspar P, Alvarez C, Berger B (1989) Chemoanatomic compartments in the human bed nucleus of the stria terminalis. Neuroscience 32:181-194.
50. Levine AS, Morley JE (1984) Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides 5:1025-1029.
51. Li TK, Lumeng L, Doolittle DP (1993) Selective breeding for alcohol preference and associated responses. Behav Genet 23:163-170.
52. Lovinger DM, White G, Weight FF (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science (Wash. DC) 243:1721-1724.
53. Macey DJ, Koob GF, Markou A (2000) CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist. Brain Res 866:82-91.
54. Markou A, Koob GF (1991) Post-cocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26.
55. McBride WJ, Li TK (1998) Animal models of alcoholism: Neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 12:339-369.
56. McDonald AJ, Shammah-Lagnado SJ, Shi C, Davis M (1999) Cortical afferents to the extended amygdala, in Advancing from the Ventral Striatum to the Extended Amygdala: Implications for Neuropsychiatry and Drug Abuse, Vol. 877, Annals of the New York Academy of Sciences (McGinty JF ed), pp 309-338, New York Academy of Sciences, New York.
57. McEwen BS (1998) Protective and damaging effects of stress mediators. N Engl J Med 338:171-179.
58. McEwen BS (2000) Allostasis and allostatic load: implications for neuropsychopharmacology. Neuropsychopharmacology 22:108-124.
59. Merlo-Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F (1995) Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15:5439-5447.
60. Nijsen MJ, Croiset G, Diamant M, De Wied D, Wiegant VM (2001) CRH signaling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats. Neuropsychopharmacology 24:1-10.
61. Olive MF, Koenig HN, Nannini MA, Hodge CW (2002) Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol Biochem Behav 72:213-220.
62. Parker RM, Herzog H (1999) Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 11:1431-1448.
63. Paterson NE, Myers C, Markou A (2000) Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats. Psychopharmacology 152:440-446.
64. Pelleymounter MA, Joppa M, Carmouche M, Cullen MJ, Brown B, Murphy B, Grigoriadis DE, Ling N, Foster AC (2000) Role of corticotropin-releasing factor (CRF) receptors in the anorexic syndrome induced by CRF. J Pharmacol Exp Ther 293:799-806.
65. Perrin M, Donaldson C, Chen R, Blount A, Berggren T, Bilezikjian L, Sawchenko P, Vale W (1995) Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc Natl Acad Sci USA 92:2969-2973.
66. Phelix CF, Paull WK (1990) Demonstration of distinct corticotropin releasing factor-containing neuron populations in the bed nucleus of the stria terminalis: a light and electron microscopic immunocytochemical study in the rat. Histochemistry 94:345-364.
67. Pompei P, Tayebaty SJ, De Caro G, Schulkin J, Massi M (1991) Bed nucleus of the stria terminalis: site for the antinatriorexic action of tachykinins in the rat. Pharmacol Biochem Behav 40:977-981.
68. Rasmussen DD, Boldt BM, Bryant CA, Mitton DR, Larsen SA, Wilkinson CW (2000) Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcohol Clin Exp Res 24:1836-1849.
69. Rassnick S, Pulvirenti L, Koob GF (1992) Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology 109:92-98.
70. Rassnick S, Heinrichs SC, Britton KT, Koob GF (1993) Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605:25-32.
71. Richter RM, Weiss F (1999) In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32:254-261.
72. Rivier C, Bruhn T, Vale W (1984) Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). J Pharmacol Exp Ther 229:127-131.
73. Roberts AJ, Cole M, Koob GF (1996) Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol Clin Exp Res 20:1289-1298.
74. Roberts AJ, McArthur RA, Hull EE, Post C, Koob GF (1998) Effects of amperozide, 8-OH-DPAT, and FG 5974 on operant responding for ethanol. Psychopharmacology 137:25-32.
75. Roberts AJ, Heyser CJ, Koob GF (1999) Operant self-administration of sweetened versus unsweetened ethanol: effects on blood alcohol levels. Alcohol Clin Exp Res 23:1151-1157.
76. Roberts AJ, Heyser CJ, Cole M, Griffin P, Koob GF (2000) Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology 22:581-594.
77. Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, Li TK (2001) Effects of concurrent access to multiple ethanol concentrations and repeated deprivations on alcohol intake of alcohol-preferring rats. Alcohol Clin Exp Res 25:1140-1150.
78. Rodriguez de Fonseca F, Carrera MRA, Navarro M, Koob GF, Weiss F (1997) Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science (Wash. DC) 276:2050-2054.
79. Roy A, Pandey SC (2002) The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol Clin Exp Res 26:796-803.
80. Russell MAH (1976) What is dependence? in Drugs and Drug Dependence (Edwards G ed), pp 182-187, Lexington Books, Lexington, MA.
81. Sajdyk TJ, Vandergriff MG, Gehlert DR (1999) Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol 368:143-147.
82. Samson HH (1987) Initiation of ethanol-maintained behavior: a comparison of animal models and their implication to human drinking, in Neurobehavioral Pharmacology, Vol. 6, Advances in Behavioral Pharmacology (Thompson T, Dews PB, Barrett JE eds), pp 221-248, Lawrence Erlbaum, Hillsdale, NJ.
83. Schulkin J, McEwen BS, Gold PW (1994) Allostasis, amygdala, and anticipatory angst. Neurosci Biobehav Rev 18:385-396.
84. Schulteis G, Markou A, Gold LH, Stinus L, Koob GF (1994) Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 271:1391-1398.
85. Schulteis G, Markou A, Cole M, Koob G (1995) Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci USA 92:5880-5884.
86. Sellers EM, Higgins GA, Sobell MB (1992) 5-HT and alcohol abuse. Trends Pharmacol Sci 13:69-75.
87. Slawecki CJ, Somes C, Ehlers CL (1999) Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y. Alcohol Alcohol 34:289-299.
88. Solomon RL, Corbit JD (1974) An opponent-process theory of motivation: 1. Temporal dynamics of affect. Psychol Rev 81:119-145.
89. Spanagel R, Hölter SM, Allingham K, Landgraf R, Zieglgänsberger W (1996) Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305:39-44.
90. Spina M, Merlo-Pich E, Chan RKW, Basso AM, Rivier J, Vale W, Koob GF (1996) Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science (Wash. DC) 273:1561-1564.
91. Sterling P, Eyer J (1988) Allostasis: a new paradigm to explain arousal pathology, in Handbook of Life Stress, Cognition and Health (Fisher S, Reason J eds), pp 629-649, John Wiley, Chichester.
92. Stewart RB, Gatto GJ, Lumeng L, Li TK, Murphy JM (1993) Comparison of alcohol-preferring (P) and nonpreferring (NP) rats on tests of anxiety and for the anxiolytic effects of ethanol. Alcohol 10:1-10.
93. Sundstrom-Poromaa I, Smith DH, Gong QH, Sabado TN, Li X, Light A, Wiedmann M, Williams K, Smith SS (2002) Hormonally regulated alpha-4-beta-2-delta GABA-A receptors are a target for alcohol. Nat Neurosci 5:721-722.
94. Swanson LW, Sawchenko PE, Rivier J, Vale W (1983) The organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-186.
95. Tabakoff B, Hoffman PL (1992) Alcohol: neurobiology, in Substance Abuse: A Comprehensive Textbook, 2nd ed (Lowinson JH, Ruiz P, Millman RB eds), pp 152-185, Williams and Wilkins, Baltimore.
96. Thiele TE, Marsh DJ, St. Marie L, Bernstein IL, Palmiter RD (1998) Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature (Lond.) 396:366-369.
97. Tsai G, Gastfriend DR, Coyle JT (1995) The glutametergic basis of human alcoholism. Am J Psychiatry 152:332-340.
98. Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, Koob GF (2002) Increased ethanol self-administration and anxiety-like behavior during acute withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol Clin Exp Res 26:1494-1501.
99. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE (2000) Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191-212.
100. Weiss F, Lorang MT, Bloom FE, Koob GF (1993) Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther 267:250-258.
101. Weiss F, Parsons LH, Schulteis G, Hyytia P, Lorang MT, Bloom FE, Koob GF (1996) Ethanol self-administration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci 16:3474-3485.
102. Zorrilla EP, Valdez GR, Weiss F (2001) Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology 158:374-381.